Dr Jakub Radocha talks to ecancer about his retrospective analysis looking at COVID-19 infection in 371 Czech multiple myeloma patients.
He reports that around 25% of multiple myeloma patients died after COVID-19 infection and around half required hospitalisation.
Dr Radocha goes on to say that there were very few risk factors that had any effect on survival - older age being one that did have a detrimental effect.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.